Skin Cancer After Transplantation: A Guide for the General Surgeon

Surgical Clinics of North America

Volumn 86, Issue 5, 2006, Pages 1257-1276

  Lewis, Kevan G ^a   Jellinek, Nathaniel ^a   Robinson Bostom, Leslie ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; DICLOFENAC; ETRETIN; FLUOROURACIL; IMIQUIMOD; IMMUNOSUPPRESSIVE AGENT; ISOTRETINOIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; RETINOID; SUNSCREEN; TACROLIMUS;

ACTINIC KERATOSIS; ARTHRALGIA; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER RISK; CANCER THERAPY; CARBON DIOXIDE LASER; CARDIOVASCULAR DISEASE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CRYOTHERAPY; CURETTAGE; DESQUAMATION; DROWSINESS; DRUG CONTRAINDICATION; DRUG DOSE REDUCTION; DRUG INDUCED HEADACHE; ELECTROSURGERY; GENERAL SURGERY; GRANULATION TISSUE; HAIR LOSS; HEALTH CARE QUALITY; HUMAN; HYPERLIPIDEMIA; HYPEROSTOSIS; HYPERTRIGLYCERIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; INTRACRANIAL HYPERTENSION; MALAISE; MOOD DISORDER; MUSCULOSKELETAL DISEASE; MYALGIA; NAUSEA; ORGAN TRANSPLANTATION; PANCREATITIS; PHOTODYNAMIC THERAPY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PSORIASIS; RECIPIENT; REVIEW; SCAR; SENSORIMOTOR NEUROPATHY; SKIN CANCER; SKIN CARCINOGENESIS; SKIN CARE; SKIN IRRITATION; SUICIDE ATTEMPT; SURGEON; SWEAT GLAND DISEASE; VISUAL DISORDER; WOUND HEALING; XEROPHTHALMIA; XEROSIS;

CHEMOPREVENTION; HUMANS; IMMUNOSUPPRESSION; ORGAN TRANSPLANTATION; PRECANCEROUS CONDITIONS; RISK FACTORS; SKIN NEOPLASMS;

EID: 33748194588     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2006.06.007     Document Type: Review

References (94)

1. Moloney F.J., Keane S., O'Kelly P., et al. The impact of skin disease following renal transplantation on quality of life. Br J Dermatol 153 3 (2005) 574-578
2. Penn I. Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transpl 7 (1994) 99-109
3. Sheil A.G., Disney A.P., Mathew T.H., et al. De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation. Transplant Proc 25 1 Pt 2 (1993) 1383-1384
4. Moloney F.J., Comber H., O'Lorcain P., et al. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 154 3 (2006) 498-504
5. Blohme I., and Larko O. Skin lesions in renal transplant patients after 10-23 years of immunosuppressive therapy. Acta Derm Venereol 70 6 (1990) 491-494
6. Bouwes Bavinck J.N., Hardie D.R., Green A., et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation 61 5 (1996) 715-721
7. Jensen P., Hansen S., Moller B., et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 40 2 Pt 1 (1999) 177-186
8. Adami J., Gabel H., Lindelof B., et al. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer 89 7 (2003) 1221-1227
9. Otley C.C., and Pittelkow M.R. Skin cancer in liver transplant recipients. Liver Transpl 6 3 (2000) 253-262
10. Ulrich C., Schmook T., Sachse M.M., et al. Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients. Dermatol Surg 30 4 Pt 2 (2004) 622-627
11. Ramsay H.M., Fryer A.A., Hawley C.M., et al. Non-melanoma skin cancer risk in the Queensland renal transplant population. Br J Dermatol 147 5 (2002) 950-956
12. Staples M.P., Elwood M., Burton R.C., et al. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust 184 1 (2006) 6-10
13. Espana A., Redondo P., Fernandez A.L., et al. Skin cancer in heart transplant recipients. J Am Acad Dermatol 32 3 (1995) 458-465
14. Webb M.C., Compton F., Andrews P.A., et al. Skin tumours posttransplantation: a retrospective analysis of 28 years' experience at a single centre. Transplant Proc 29 1-2 (1997) 828-830
15. Euvrard S., Kanitakis J., Pouteil-Noble C., et al. Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol 33 2 Pt 1 (1995) 222-229
16. Ong C.S., Keogh A.M., Kossard S., et al. Skin cancer in Australian heart transplant recipients. J Am Acad Dermatol 40 1 (1999) 27-34
17. Hollenbeak C.S., Todd M.M., Billingsley E.M., et al. Increased incidence of melanoma in renal transplantation recipients. Cancer 104 9 (2005) 1962-1967
18. Kasiske B.L., Snyder J.J., Gilbertson D.T., et al. Cancer after kidney transplantation in the United States. Am J Transplant 4 6 (2004) 905-913
19. Penn I., and First M.R. Merkel's cell carcinoma in organ recipients: report of 41 cases. Transplantation 68 11 (1999) 1717-1721
20. Martinez J.C., Otley C.C., Stasko T., et al. Defining the clinical course of metastatic skin cancer in organ transplant recipients: a multicenter collaborative study. Arch Dermatol 139 3 (2003) 301-306
21. Berg D., and Otley C.C. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol 47 1 (2002) 1-17 quiz 8-20
22. Penn I. Tumors after renal and cardiac transplantation. Hematol Oncol Clin N Am 7 2 (1993) 431-445
23. Lewis K.G., and Weinstock M.A. Nonmelanoma skin cancer mortality (1988-2000): the Rhode Island follow-back study. Arch Dermatol 140 7 (2004) 837-842
24. Buell J.F., Gross T.G., and Woodle E.S. Malignancy after transplantation. Transplantation 80 2 Suppl (2005) S254-S264
25. Grossman D., and Leffell D.J. The molecular basis of nonmelanoma skin cancer: new understanding. Arch Dermatol 133 10 (1997) 1263-1270
26. Brash D.E., Ziegler A., Jonason A.S., et al. Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion. J Investig Dermatol Symp Proc 1 2 (1996) 136-142
27. Carucci J.A. Cutaneous oncology in organ transplant recipients: meeting the challenge of squamous cell carcinoma. J Invest Dermatol 123 5 (2004) 809-816
28. Parrish J.A. Immunosuppression, skin cancer, and ultraviolet A radiation. N Engl J Med 353 25 (2005) 2712-2713
29. Euvrard S., Chardonnet Y., Pouteil-Noble C., et al. Association of skin malignancies with various and multiple carcinogenic and noncarcinogenic human papillomaviruses in renal transplant recipients. Cancer 72 7 (1993) 2198-2206
30. Harwood C.A., Surentheran T., Sasieni P., et al. Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin. Br J Dermatol 150 5 (2004) 949-957
31. Purdie K.J., Surentheran T., Sterling J.C., et al. Human papillomavirus gene expression in cutaneous squamous cell carcinomas from immunosuppressed and immunocompetent individuals. J Invest Dermatol 125 1 (2005) 98-107
32. Chang Y., Cesarman E., Pessin M.S., et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266 5192 (1994) 1865-1869
33. Schwartz R.A. Kaposi's sarcoma: an update. J Surg Oncol 87 3 (2004) 146-151
34. Cattani P., Capuano M., Graffeo R., et al. Kaposi's sarcoma associated with previous human herpesvirus 8 infection in kidney transplant recipients. J Clin Microbiol 39 2 (2001) 506-508
35. Durando B., and Reichel J. The relative effects of different systemic immunosuppressives on skin cancer development in organ transplant patients. Dermatol Ther 18 1 (2005) 1-11
36. Paul C.F., Ho V.C., McGeown C., et al. Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study. J Invest Dermatol 120 2 (2003) 211-216
37. Hiesse C., Larue J.R., Kriaa F., et al. Incidence and type of malignancies occurring after renal transplantation in conventionally and in cyclosporine-treated recipients: single-center analysis of a 20-year period in 1600 patients. Transplant Proc 27 4 (1995) 2450-2451
38. Penn I. Cancers in cyclosporine-treated vs azathioprine-treated patients. Transplant Proc 28 2 (1996) 876-878
39. Glover M.T., Deeks J.J., Raftery M.J., et al. Immunosuppression and risk of non-melanoma skin cancer in renal transplant recipients. Lancet 349 9049 (1997) 398
40. Jensen P., Hansen S., Moller B., et al. Are renal transplant recipients on CsA-based immunosuppressive regimens more likely to develop skin cancer than those on azathioprine and prednisolone?. Transplant Proc 31 1-2 (1999) 1120
41. Kreis H., Oberbauer R., Campistol J.M., et al. Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal. J Am Soc Nephrol 15 3 (2004) 809-817
42. Kahan B.D., Yakupoglu Y.K., Schoenberg L., et al. Low incidence of malignancy among sirolimus/cyclosporine-treated renal transplant recipients. Transplantation 80 6 (2005) 749-758
43. Euvrard S., Ulrich C., and Lefrancois N. Immunosuppressants and skin cancer in transplant patients: focus on rapamycin. Dermatol Surg 30 4 Pt 2 (2004) 628-633
44. Mathew T., Kreis H., and Friend P. Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies. Clin Transplant 18 4 (2004) 446-449
45. Lindelof B., Granath F., Dal H., et al. Sun habits in kidney transplant recipients with skin cancer: a case-control study of possible causative factors. Acta Derm Venereol 83 3 (2003) 189-193
46. Lampros T.D., Cobanoglu A., Parker F., et al. Squamous and basal cell carcinoma in heart transplant recipients. J Heart Lung Transplant 17 6 (1998) 586-591
47. Naldi L., Fortina A.B., Lovati S., et al. Risk of nonmelanoma skin cancer in Italian organ transplant recipients. A registry-based study. Transplantation 70 10 (2000) 1479-1484
48. Otley C.C., Cherikh W.S., Salasche S.J., et al. Skin cancer in organ transplant recipients: effect of pretransplant end-organ disease. J Am Acad Dermatol 53 5 (2005) 783-790
49. Garbe C., Buttner P., Weiss J., et al. Associated factors in the prevalence of more than 50 common melanocytic nevi, atypical melanocytic nevi, and actinic lentigines: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol 102 5 (1994) 700-705
50. Otley C.C., Hirose R., and Salasche S.J. Skin cancer as a contraindication to organ transplantation. Am J Transplant 5 9 (2005) 2079-2084
51. Chuang T.Y., Popescu N.A., Su W.P., et al. Squamous cell carcinoma. A population-based incidence study in Rochester. Minn Arch Dermatol 126 2 (1990) 185-188
52. Jemal A., Tiwari R.C., Murray T., et al. Cancer statistics, 2004. CA Cancer J Clin 54 1 (2004) 8-29
53. Balch C.M., Buzaid A.C., Soong S.J., et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19 16 (2001) 3635-3648
54. Karagas M.R., Stannard V.A., Mott L.A., et al. Use of tanning devices and risk of basal cell and squamous cell skin cancers. J Natl Cancer Inst 94 3 (2002) 224-226
55. Westerdahl J., Olsson H., Masback A., et al. Use of sunbeds or sunlamps and malignant melanoma in southern Sweden. Am J Epidemiol 140 8 (1994) 691-699
56. Moloney F.J., Almarzouqi E., O'Kelly P., et al. Sunscreen use before and after transplantation and assessment of risk factors associated with skin cancer development in renal transplant recipients. Arch Dermatol 141 8 (2005) 978-982
57. Mahe E., Morelon E., Fermanian J., et al. Renal-transplant recipients and sun protection. Transplantation 78 5 (2004) 741-744
58. Cowen E.W., and Billingsley E.M. Awareness of skin cancer by kidney transplant patients. J Am Acad Dermatol 40 5 Pt 1 (1999) 697-701
59. Rowe D.E., Carroll R.J., and Day Jr. C.L. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol 26 6 (1992) 976-990
60. Stasko T., Brown M.D., Carucci J.A., et al. Guidelines for the management of squamous cell carcinoma in organ transplant recipients. Dermatol Surg 30 4 Pt 2 (2004) 642-650
61. Mehrany K., Byrd D.R., Roenigk R.K., et al. Lymphocytic infiltrates and subclinical epithelial tumor extension in patients with chronic leukemia and solid-organ transplantation. Dermatol Surg 29 2 (2003) 129-134
62. Brodland D.G., and Zitelli J.A. Surgical margins for excision of primary cutaneous squamous cell carcinoma. J Am Acad Dermatol 27 2 Pt 1 (1992) 241-248
63. Lawrence N., and Cottel W.I. Squamous cell carcinoma of skin with perineural invasion. J Am Acad Dermatol 31 1 (1994) 30-33
64. Clayton A.S., and Stasko T. Treatment of nonmelanoma skin cancer in organ transplant recipients: review of responses to a survey. J Am Acad Dermatol 49 3 (2003) 413-416
65. Ramos H.C., Reyes J., Abu-Elmagd K., et al. Weaning of immunosuppression in long-term liver transplant recipients. Transplantation 59 2 (1995) 212-217
66. Otley C.C., Coldiron B.M., Stasko T., et al. Decreased skin cancer after cessation of therapy with transplant-associated immunosuppressants. Arch Dermatol 137 4 (2001) 459-463
67. Otley C.C., and Maragh S.L. Reduction of immunosuppression for transplant-associated skin cancer: rationale and evidence of efficacy. Dermatol Surg 31 2 (2005) 163-168
68. Euvrard S., Kanitakis J., Pouteil-Noble C., et al. Aggressive squamous cell carcinomas in organ transplant recipients. Transplant Proc 27 2 (1995) 1767-1768
69. Moloney F.J., Kelly P.O., Kay E.W., et al. Maintenance versus reduction of immunosuppression in renal transplant recipients with aggressive squamous cell carcinoma. Dermatol Surg 30 4 Pt 2 (2004) 674-678
70. Dantal J., Hourmant M., Cantarovich D., et al. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet 351 9103 (1998) 623-628
71. Otley C.C., Berg D., Ulrich C., et al. Reduction of immunosuppression for transplant-associated skin cancer: expert consensus survey. Br J Dermatol 154 3 (2006) 395-400
72. DiGiovanna J.J. Posttransplantation skin cancer: scope of the problem, management, and role for systemic retinoid chemoprevention. Transplant Proc 30 6 (1998) 2771-2775 [discussion 6-8]
73. Kraemer K.H., DiGiovanna J.J., Moshell A.N., et al. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N Engl J Med 318 25 (1988) 1633-1637
74. Peck G.L., DiGiovanna J.J., Sarnoff D.S., et al. Treatment and prevention of basal cell carcinoma with oral isotretinoin. J Am Acad Dermatol 19 1 Pt 2 (1988) 176-185
75. Bavinck J.N., Tieben L.M., Van der Woude F.J., et al. Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study. J Clin Oncol 13 8 (1995) 1933-1938
76. McKenna D.B., and Murphy G.M. Skin cancer chemoprophylaxis in renal transplant recipients: 5 years of experience using low-dose acitretin. Br J Dermatol 140 4 (1999) 656-660
77. Harwood C.A., Leedham-Green M., Leigh I.M., et al. Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study. Arch Dermatol 141 4 (2005) 456-464
78. Chen K., Craig J.C., and Shumack S. Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomized controlled trials. Br J Dermatol 152 3 (2005) 518-523
79. George R., Weightman W., Russ G.R., et al. Acitretin for chemoprevention of non-melanoma skin cancers in renal transplant recipients. Australas J Dermatol 43 4 (2002) 269-273
80. de Sevaux R.G., Smit J.V., de Jong E.M., et al. Acitretin treatment of premalignant and malignant skin disorders in renal transplant recipients: clinical effects of a randomized trial comparing two doses of acitretin. J Am Acad Dermatol 49 3 (2003) 407-412
81. Kovach B.T., Sams H.H., and Stasko T. Systemic strategies for chemoprevention of skin cancers in transplant recipients. Clin Transplant 19 6 (2005) 726-734
82. DiGiovanna J.J., Sollitto R.B., Abangan D.L., et al. Osteoporosis is a toxic effect of long-term etretinate therapy. Arch Dermatol 131 11 (1995) 1263-1267
83. Summey B.T., and Yosipovitch G. Glucocorticoid-induced bone loss in dermatologic patients: an update. Arch Dermatol 142 1 (2006) 82-90
84. Wakeline S.H., and Maibach H.I. Handbook of systemic drug treatment in dermatology (2004), Manson Publishing Ltd., London
85. Miles S., McGlathery W., and Abernathie B. The importance of screening for laser-assisted in situ keratomileusis operation (LASIK) before prescribing isotretinoin. J Am Acad Dermatol 54 1 (2006) 180-181
86. Geiger J.M., and Walker M. Is there a reproductive safety risk in male patients treated with acitretin (neotigason/soriatane?. Dermatology 205 2 (2002) 105-107
87. Neuhaus I.M., and Tope W.D. Practical retinoid chemoprophylaxis in solid organ transplant recipients. Dermatol Ther 18 1 (2005) 28-33
88. Tan S.R., and Tope W.D. Effect of acitretin on wound healing in organ transplant recipients. Dermatol Surg 30 4 Pt 2 (2004) 667-673
89. Odom R. Managing actinic keratoses with retinoids. J Am Acad Dermatol 39 2 Pt 3 (1998) S74-S78
90. Euvrard S., Verschoore M., Touraine J.L., et al. Topical retinoids for warts and keratoses in transplant recipients. Lancet 340 8810 (1992) 48-49
91. Dragieva G., Hafner J., Dummer R., et al. Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients. Transplantation 77 1 (2004) 115-121
92. Brown V.L., Atkins C.L., Ghali L., et al. Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: randomized, double-blind, placebo-controlled trial. Arch Dermatol 141 8 (2005) 985-993
93. Smith K.J., Germain M., and Skelton H. Squamous cell carcinoma in situ (Bowen's disease) in renal transplant patients treated with 5% imiquimod and 5% 5-fluorouracil therapy. Dermatol Surg 27 6 (2001) 561-564
94. Otley C.C. Organization of a specialty clinic to optimize the care of organ transplant recipients at risk for skin cancer. Dermatol Surg 26 7 (2000) 709-712